The Tear Film & Ocular Surface Society (TFOS) has made available a patientfocused Executive Summary of the TFOS DEWS II Report, providing patients with access to accurate, relevant and comprehensive information about dry eye disease.
“TFOS has created a credible, clear and usable summary of the TFOS DEWS II report for patients,” explained Dr. David A. Sullivan, Schepens Eye Research Institute/Harvard Medical School, and TFOS Founder. “This summary is written in lay language and contains new figures related to the classification and pathophysiology of dry eye disease. In the near future we also hope to make this patientfocused Executive Summary available in Wikipedia.”
The goal of the TFOS DEWS II initiative, which took over two years and involved 150 experts, was to achieve a global consensus concerning multiple aspects of dry eye disease. More specifically, it sought to update the definition and classification of the disease; evaluate critically the epidemiology, pathophysiology, mechanism, and impact of this disorder; develop recommendations for the diagnosis, management and therapy of this disease; and recommend the design of clinical trials to assess future interventions for dry eye disease treatment. The TFOS DEWS II initiative was very important, because dry eye disease is a global problem, responsible for many patient visits to eye care practitioners.
The TFOS DEWS II Report was published in The Ocular Surface journal in July 2017. Since then, TFOS has organised events and seminars worldwide. Visit https://bit.ly/2MbHHrk.
